You have 9 free searches left this month | for more free features.

Condition

Glioma (2)

Acute Myeloid Leukemia (AML) (1)

Advanced Malignancies That Harbor IDHR132 Mutations (1)

Overall Status

Withdrawn (3)

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (2)

Sponsor

Novartis Pharmaceuticals (2)

NYU Langone Health (1)

University of Texas Southwestern Medical Center (1)

Collaborator

Novartis (1)

Intervention

idh305 (4)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

idh305

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Malignancies That Harbor IDHR132 Mutations Trial in Worldwide (IDH305)

Active, not recruiting

Advanced Malignancies That Harbor IDHR132 Mutations

IDH305

Boston, Massachusetts
+12 more

Dec 9, 2021

Acute Myeloid Leukemia (AML) Trial (IDH305)

Withdrawn

Acute Myeloid Leukemia (AML)

IDH305

(no location specified)

Apr 8, 2019

Glioma Trial in New York (IDH305)

Withdrawn

Glioma

IDH305

New York, New York

Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Cen

Dec 18, 2017

Glioma Trial (IDH305)

Withdrawn

Glioma

IDH305

(no location specified)

Oct 9, 2017